how big is the glp 1 market Global GLP-1 Receptor Agonist Size, Forecast GLP-1 Drugs Market Size to
Description
I really think that's where it should begin someone who you know, someone who you trust, someone who knows you
60 HolstJJGromadaJNauckMA
The investigation specifically showed that these drugs did not increase the risk of any fractures, confirming their safety profile in clinical practice ( 4.6 Ophthalmological effects 4.6.1 Glaucoma GLP-1R agonists exhibit anti-inflammatory and neuroprotective properties, suggesting they could also be beneficial in neurodegenerative diseases ( A recent registry-based case-control study, summarized in Table 2 , involving 1,961 patients found that the use of GLP-1R agonists is linked to a lower risk of glaucoma (Sterling et al., 2021 (79)
Being overweight can put individuals at high risk of a wide range of health problems
The fat metabolism theory suggests GIPs effects on adipose tissue are crucial
Phase 2 trial data showing up to 24% body weight reduction over 48 weeks put it ahead of every approved therapy currently on the market
